You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., June 22, 2015 /PRNewswire/ -- Astellas today announced that Julie Monzo has been appointed to the newly created role of senior manager, Global Medical and Development (GMD) communications, as part of the Corporate Affairs department. Monzo will report to Andrew Lewis, head of communications, GMD, and will lead both internal and external global communications programs for the functional groups that comprise GMD, including Clinical Development, Medical Affairs, Pharmacovigilance, Quality Assurance and Regulatory Affairs.
"As a leader in the healthcare community, it is essential for the communications function at Astellas to align its employees with organizational priorities and communicate the Company's scientific and medical expertise to patients, healthcare providers and researchers around the world," said Jeff Winton, senior vice president, chief communications officer, Corporate Affairs. "Julie's deep experience in this space will be invaluable in helping achieve these goals."
Monzo most recently served as senior manager, enterprise communications and public relations at the College of American Pathologists. She previously worked at the McDonald's Corporation and various public relations and advertising agencies. Monzo earned a bachelor's degree in communication studies from the University of Iowa.
Winton oversees the newly formed Corporate Affairs department at Astellas. This department combines State and Federal Government Affairs, Corporate, Employee and Business Communications, Advocacy, Corporate Branding, Corporate Social Responsibility and Corporate Events, effectively uniting the Astellas voice among all internal and external stakeholders.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. For more information on Astellas, please visit our website at www.astellas.us, follow us on Twitter at www.twitter.com/AstellasUS or like our Facebook page at www.facebook.com/AstellasUS.
Logo - http://photos.prnewswire.com/prnh/20140416/84970
SOURCE Astellas
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.